Author

M. Lustig

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Bioengineering· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:clustering· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:imaging· 1 Approach:statistical model· 1

Frequent Co-Authors

B. Bruncsics· 1 shared C. A. Sarkar· 1 shared C. R. Bertozzi· 1 shared F. Tan· 1 shared I. Ibarlucea-Benitez· 1 shared J. C. Stark· 1 shared J. V. Ravetch· 1 shared M. A. Gray· 1 shared

Activity by Year

2022-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperBioengineering

B. Bruncsics

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Pulmonary Ventilation Analysis Using 1H Ultra-Short Echo Time (UTE) Lung MRI: A Reproducibility Study

F. Tan, X. Zhu, M. Chan, N. Deveshwar, M. M. Willmering, M. Lustig, P. E. Z. Larson

This study evaluates methods for quantifying pulmonary ventilation using 1H UTE MRI, finding that cyclic b-spline registration and specific ventilation provide the most reproducible results.

bioRxiv · Oct 22, 2023 · PreprintBioengineering

Antibody-lectin chimeras for glyco-immune checkpoint blockade

J. C. Stark, M. A. Gray, S. Wisnovsky, I. Ibarlucea-Benitez, M. Lustig, N. M. Riley, M. K. Ribi, W. J. Errington, B. Bruncsics, C. A. Sarkar, T. Valerius, J. V. Ravetch, C. R. Bertozzi

This paper introduces antibody-lectin chimeras (AbLecs) as a new immunotherapy approach that blocks glyco-immune checkpoints, enhancing cancer immune responses and synergizing with existing checkpoint inhibitors.

bioRxiv · Oct 26, 2022Bioengineering